IMI Members
IMI Ongoing Projects
The Innovative Medicines Initiative (IMI) now has 40 projects that are up and running as a result of the successful launches of its first six Calls for proposals.
All Projects
- ABIRISK
Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk
- BioVacSafe
Biomarkers for Enhanced Vaccine Immunosafety
- BTCure
Be The Cure
- CHEM21
Chemical manufacturing methods for the 21st century pharmaceutical industries
- COMBACTE
Combatting Bacterial Resistance in Europe
- COMPACT
Collaboration on the optimisation of macromolecular pharmaceutical access to cellular targets
- DDMoRe
Drug Disease Model Resources
- DIRECT
Diabetes research on patient stratification
- EHR4CR
Electronic Health Records Systems for Clinical Research
- ELF
European Lead Factory
- EMIF
European Medical Information Framework
- EMTRAIN
European Medicines Research Training Network
- eTOX
Integrating bioinformatics and chemoinformatics approaches for the development of Expert systems allowing the in silico prediction of toxicities
- eTRIKS
Delivering European Translational Information & Knowledge Management Services
- EU-AIMS
European Autism Interventions - a Multicentre Study for Developing New Medications
- Eu2P
European programme in Pharmacovigilance and Pharmacoepidemiology
- EUPATI
European Patients' Academy on Therapeutic Innovation
- EUROPAIN
Understanding chronic pain and improving its treatment
- IMIDIA
Improving beta-cell function and identification of diagnostic biomarkers For treatment monitoring in diabetes
- K4DD
Kinetics for Drug Discovery
- MARCAR
Biomarkers and molecular tumour classification for non-genotoxic carcinogenesis
- MIP-DILI
Mechanism-Based Integrated Systems for the Prediction of Drug-Induced Liver Injury
- NEWMEDS
Novel methods leading to new medications in depression and schizophrenia
- Onco Track
Methods for systematic next generation oncology biomarker development
- Open PHACTS
The Open Pharmacological Concepts Triple Store
- ORBITO
Oral biopharmaceutics tools
- Pharma-Cog
Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development
- Pharmatrain
Pharmaceutical Medicine Training Programme
- Predect
New models for preclinical evaluation of drug efficacy in common solid tumours
- PreDiCT-TB
Model-based preclinical development of anti-tuberculosis drug combinations
- PRO-active
Physical Activity as a Crucial Patient Reported Outcome in COPD
- PROTECT
Pharmacoepidemiological research on outcomes of therapeutics by a European consortium
- Quic-Concept
Quantative imaging in cancer:connecting cellular process with therapy
- RAPP-ID
Development of rapid point-of-care test platforms for infectious diseases
- SAFE-T
Safer and Faster Evidence-based Translation
- SafeSciMET
European Modular Education and Training Programme in Safety Sciences for Medicines
- STEMBANCC
Stem cells for biological assays of novel drugs and predictive toxicology
- SUMMIT
Surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools
- TRANSLOCATION
Molecular basis of the bacterial cell wall permeability
- U-BIOPRED
Unbiased biomarkers for the prediction of respiratory disease outcomes
Innovative Medicines Initiative 2010